Our Future 100: 2020 report predicted the rise of magic mushrooms. Now, thanks to recent medical, legal and financial developments, we’re reminded of a major cannabis push from just a few years ago. As the industry continues to grow and research becomes more available, psychedelic mushrooms may soon have a shop of their own. Where is the $2 million industry headed?
Are magic mushrooms the next big thing in health and wellness? We round up the top five developments in psychedelic health.
- Is psilocybin the new cannabis? Yes, according to Shark Tank investor Kevin O’Leary, who told CNBC that the investment potential of psychedelic drugs “far exceeds” that of cannabis.
- Groundbreaking research reveals that effective psychedelic treatment paired with therapy can aid in mental health treatments. The New England Journal of Medicine reported a study in April 2021 that psilocybin, the psychoactive compound in magic mushrooms, was effective in treating PTSD and depression. In a first-of-its-kind clinical trial, Nature Medicine published a study in May 2021 that showed MDMA doses paired with “psychedelic assisted therapy” helped subdue the effects of PTSD.
- Telemedicine startup NUE Life Health raised $3.3 million in June 2021 top pioneer psychedelic-assisted therapies in their “next-generation mental wellness solution.”
- Psychedelic “smart shops” may be on the horizon. Silo Wellness and mushroom company Mushe announced in March 2021 that they will open a psychedelic mushroom storefront in Jamaica, marking the first of its kind in the Americas. CEO Douglas K. Gordon of Silo Wellness anticipates “a not-so-distant future when smart shops will be as commonplace as cannabis dispensaries around the world, enabling people to shop for and learn about magic mushrooms and other psychedelics responsibly and freely.”
- While research might break the bank, it won’t break the law. Washington, D.C. decriminalized psilocybin in March of 2021, and additional states currently have similar pending legislation. Oregon was the first to legalize its therapeutic use in 2020, and it was decriminalized in Denver, Colorado and Oakland, California in 2019.
Why it’s interesting:
There is talk that the FDA may approve therapeutic psychoactive compounds as soon as 2023, and public use of the compounds may increase in the meantime. Psilocybin, not unlike cannabis, may be the psychedelic future in health and wellness.
Main image: Psilocybe cyanescens mushrooms. Courtesy of Imperial College London.
Please provide your contact information to continue.
Related Content
News
LIA Awards 2025: VML’s Creativity Recognized with 50 Accolades
VML earns 5 Golds, 14 Silvers, 17 Bronzes, and 14 Finalists at the 2025 London International Awards
Read Article 
News
Victoria Cole Appointed CEO to Lead VML’s Next Chapter of Growth in Latin America
Juan Pablo Jurado to retire in early 2026; Emiliano Galvan promoted to CEO of VML Argentina
Read Article